Here’s whether Cardinal Health, Inc. (CAH) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); strong 1-year return of +39.5%. Concerns: 50-day MA is falling (-0.16% over 10 days); RSI 81 — overbought, elevated pullback risk. Currently 4.2% off its 52-week high. Score: +2/7.
CAH is in a confirmed uptrend, trading above both its 50-day ($202.78) and 200-day ($195.75) moving averages. With an RSI of 81.1, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of +39.5% compares to +22.9% for SPY (beat the market by 16.6%).
$10,000 invested 1 year ago→ $13,945 today
vs. S&P 500 (SPY) — same period beat market by 16.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($195.75)
✓Above 50-day MA ($202.78)
!RSI(14) neutral zone (30–70) — currently 81.1
✓Positive return (+39.5%)
✓Within 10% of period high (−4.2%)
Period Range $223.85
$137.75$233.60
RSI (14) 81.1
0 · OversoldOverbought · 100
Key Metrics
Price$223.85
Period Return+39.5%
Period High$233.60
Period Low$137.75
Drawdown−4.2%
MA-50$202.78
MA-200$195.75
RSI (14)81.1
Avg Volume (30d)2.4M
vs. SPYbeat by 16.6%
Return Rank#400 of 1246
Trend Signals
Price is above the 200-day moving average ($195.75)
Price is above the 50-day moving average ($202.78)